elearning

Regístrese gratis y obtenga acceso ilimitado a nuestra extensa biblioteca de elearning
Gane puntos CME y realice un seguimiento de su actividad de aprendizaje con cientos de horas de educación médica continua.
Bookmark and Share

From Smoking to Quitting

This module focuses on how a smoker can make an effective quit attempt, including; abrupt and gradual cessation and how effective these methods are when compared to a tobacco reduction approach.

This e-learning course is comprised of 8 modules exploring how to deliver an effective cessation programme to your patients. The content was developed alongside experts in Tobacco Cessation from King's College London.

Published November 2017.

From Smoking to Quitting
Modulo
English
0 CME Points

Público destinatarios

This module is for health professionals/students looking to expand their knowledge in the field of tobacco addiction with a focus on tobacco dependence treatment.

Objetivos educativos

Participants will gain knowledge and understanding of:

  • The different routes to quitting or reducing harm from tobacco.

Requisitos del sistema

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Política de divulgación

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.

Soporte

Production of this module was funded by an unrestricted grant from Pfizer.